HR 3821 United States House · 119th Congress

ADINA Act

This bill requires drug labels to clearly state if a medication contains major food allergens (like peanuts, dairy, or shellfish) or gluten from grains (such as wheat, barley, or rye). It applies to human drugs sold in the U.S. and mandates manufacturers to identify these specific ingredients on labels. The requirement takes effect within two years of the bill's passage, giving companies time to update packaging. This directly affects drug manufacturers and helps people with allergies make safer choices by providing clear ingredient information.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2025
Committee Review
Floor Vote
President
Introduced Jun 6, 2025 Last action Jun 6, 2025